Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 26, 2020

Primary Completion Date

April 10, 2024

Study Completion Date

April 10, 2024

Conditions

Hereditary Diffuse Gastric Cancer

Interventions

GENETIC

Liquid biopsies (blood, gastric fluid).

Next generation sequencing of a panel of diffuse gastric cancer genes, methylation analysis. Samples collected during routine screening endoscopy.

Trial Locations (1)

Hopital Pitié Salpetrière, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04253106 - Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer | Biotech Hunter | Biotech Hunter